Juvenile myoclonic epilepsy as a spectrum disorder: mechanisms of drug resistance and precision management
{{output}}
Juvenile myoclonic epilepsy (JME) has traditionally been regarded as a homogeneous and pharmacoresponsive epilepsy syndrome. However, a substantial proportion of patients do not achieve sustained seizure freedom, challenging this concept of benignity. Increasi... ...
